Table 3:

Count and proportion of visits missing staging information in each system and proportion of all patients with at least one visit with most-severe stage

Classification System	Total visits	Number of staged visits	Number of non-evaluable† visits	Proportion of all visits non-evaluable	Average Proportion Missing Per Patient††	Most Severe Stage	Proportion of Patients with at least one most-severe score	Proportion all patients with at least one most-severe score, excluding patients with only non-evaluable stages
CAPARROTTI	1063	626	437	0.411	0.423	4	0.151	0.182
CLAYMAN	1063	989	74	0.070	0.054	2	0.835	0.847
COFFIN	1063	202	861	0.810	0.783	Major	0.057	0.152
CTCAE	1063	867	196	0.184	0.206	3	0.057	0.066
GLANZMANN	1063	379	684	0.643	0.794	2	0.165	0.449
KARAGOZOGLU	1063	637	426	0.401	0.434	3	0.061	0.088
LYONS	1063	355	708	0.666	0.712	4	0.071	0.176
MARX	1063	160	903	0.849	0.926	3	0.024	0.185
MORTON	1063	170	893	0.840	0.800	Major	0.057	0.164
NOTANI	1063	878	185	0.174	0.209	3	0.113	0.132
RadORN	1063	1063	0	0.000	0.000	3	0.057	0.057
RTOG/EORTC	1063	872	191	0.180	0.193	4	0.009	0.011
SCHWARTZ	1063	728	335	0.315	0.323	3b	0.019	0.025
SOMA	1063	763	300	0.282	0.313	3	0.075	0.116
STORE	1063	983	80	0.075	0.065	4	0.038	0.047
SHAW	1063	574	489	0.460	0.501	3	0.047	0.049
TSAI	1063	699	364	0.342	0.362	4	0.042	0.057

^†Non-evaluable: missing sufficient data to determine stage from medical chart review.

^††average proportion of visits where no stage could be generated, per patient